A large retrospective analysis of 237,043 patients with hip or knee OA, including 23,000 individuals exposed to GLP-1 agonists for at least 1 year, found that arthroplasty risk at 1 year was reduced by approximately 40% for hip replacement and 25% for knee replacement
Immunofluorescence results showed a significant increase in FOXO4 and p53bp1 foci within the nucleus of senescent cells compared to those in dividing cells (Figure
10.1038/nchembio.2238 51 KhorsandiK.KianmehrZ.HosseinmardiZ.HosseinzadehR
Good to know about Vitamin B12
Lilly and Novos marketing challenges also signal whats ahead as additional players including AstraZeneca, Pfizer, Roche, and Structure Therapeutics look to bring their own obesity pills to market
Your DDAVP Nasal Spray has been filled with extra medicine for your priming sprays